Herbalife LTD 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NYSE
Herbalife announced second quarter 2026 net sales growth of 5.4% year-over-year, exceeding guidance on a constant currency basis, alongside the planned retirement of CFO John DeSimone and the appointment of Scott Schaefer.
NYSE
Herbalife Ltd. announced first quarter 2026 financial results, reporting net sales growth and adjusted EBITDA above guidance, and raising full-year outlook.
NYSE
Herbalife Ltd. announced the closing of an $800 million senior secured notes offering and amendments to its credit facility, refinancing existing debt and extending maturities.
NYSE
Herbalife Ltd. announced preliminary Q1 2026 results, with net sales and adjusted EBITDA expected to surpass guidance, driven by strong performance in Asia Pacific.
NYSE
Herbalife Ltd. reported third-quarter 2025 financial results, with net sales of $1.3 billion exceeding guidance and North America returning to year-over-year growth.
NYSE
Herbalife Ltd. reported second-quarter 2025 financial results, with adjusted EBITDA exceeding guidance and a subsequent raise in full-year net sales and adjusted EBITDA outlook.
NYSE
Herbalife Ltd. and its subsidiary HLF Financing, Inc. have issued a notice to redeem $50.0 million aggregate principal amount of their 7.875% Senior Notes due 2025.
NYSE
Herbalife's Q1 2025 net sales reached $1.2 billion, hitting the midpoint of its guidance, while adjusted EBITDA exceeded expectations, leading to an updated full-year guidance.
NYSE
Herbalife Ltd. held its 2025 annual general meeting, where shareholders elected directors, approved executive compensation on an advisory basis, and ratified the appointment of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2025.
NYSE
Herbalife reports Q4 net sales at the high end of guidance, with growth excluding FX headwinds, and announces Stephan Gratziani as the new CEO, succeeding Michael Johnson who will become Executive Chairman.
NYSE
Herbalife Ltd. announces a new employment agreement with CEO Michael O. Johnson, extending his tenure through December 31, 2025, with revised compensation terms.
NYSE
Herbalife Ltd. announced the redemption of $65 million of its 7.875% Senior Notes due 2025.
NYSE
Herbalife reported third-quarter results with net sales in line with expectations, adjusted EBITDA exceeding guidance, and an increase in distributor recruiting worldwide.
NYSE
Herbalife Ltd. has appointed Perkins Miller to its Compensation Committee, effective October 24, 2024.
NYSE
Herbalife reported second quarter results with adjusted EBITDA exceeding guidance and raised its full-year adjusted EBITDA outlook, despite a slight dip in net sales.
NYSE
Herbalife Ltd. has appointed Perkins Miller as a new director to fill a newly created seat on its Board of Directors, effective June 25, 2024.
NYSE
Herbalife reported a 1.0% year-over-year net sales increase in the first quarter of 2024, driven by a 2.4% increase on a constant currency basis, and raised its full-year adjusted EBITDA guidance.
NYSE
Herbalife has successfully closed a $1.6 billion senior secured refinancing, including $800 million in senior secured notes and $800 million in amended credit facilities.
NYSE
Herbalife has announced the pricing of an upsized $800 million senior secured notes offering due in 2029, with a 12.25% interest rate.
NYSE
Herbalife plans to offer $700 million in senior secured notes to repay existing debt and for general corporate purposes.
NYSE
Herbalife Ltd. announced the appointment of Troy Hicks as Chief Operating Officer, succeeding Frank Lamberti who will become Chief Commercial Officer, both effective May 31, 2024.
NYSE
Herbalife has amended its previous 8-K filing to disclose additional details regarding the compensation package for newly appointed Chief Financial Officer, John DeSimone, including a $7.25 million stock appreciation rights award.
NYSE
Herbalife has appointed John DeSimone as CFO, replacing Alex Amezquita, and initiated financial guidance for 2024, alongside a restructuring plan expected to yield significant savings.
NYSE
Herbalife Ltd. has appointed Michael J. Levitt to its Board of Directors, filling a vacancy created by the resignation of Kevin M. Jones.
NYSE
Herbalife announced year-over-year net sales growth in the fourth quarter of 2023, alongside the initiation of a debt refinancing process.